Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

Clinical trial NCT06420076 · RECRUITING

Trial details

NCT number: NCT06420076
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T Cell Lymphoma T Cell Leukemia T-cell Acute Lymphoblastic Leukemia T-Cell Lymphoma of CNS T Cell Prolymphocytic Leukemia T Cell Childhood ALL

Start date: 2024-07-10
Primary completion: 2025-12-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.